New Studies Reveal Biological Variability and Liver Metabolism Links in Down Syndrome

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome have published two separate studies detailing biological differences among individuals with Down syndrome. The first study maps biological variability linked to co-occurring medical conditions, while the second identifies specific alterations in liver metabolism that may be influenced by diet.

Study 1: Biological Atlas of Variable Medical Complexity

Published in Nature Communications, this study analyzed blood samples from participants in the Human Trisome Project. Researchers mapped changes in gene expression, protein levels, metabolites, and immune cell types across 100 clinical traits. The analysis produced an atlas of biological processes associated with variable medical complexity in Down syndrome.

"This atlas provides a foundational map of how biological processes differ among individuals with Down syndrome, linked directly to their medical histories."

Specific Discoveries

• Individuals with Down syndrome and obesity showed changes in hormonal circuits, metabolism, and systemic inflammation.
• Those with a history of specific congenital heart defects demonstrated persistent biosignatures of immune dysregulation and cardiac stress.

The Human Trisome Project is one of the largest studies of Down syndrome, including extensive clinical data, multi-omics datasets, and a large biobank. The research relied on self-reported medical histories and expert curation of medical records provided by participants and caregivers.

The research team plans follow-up studies to develop biomarkers and tailored therapeutic options for subsets of the Down syndrome population.

Study 2: Liver Metabolism Alterations and Dietary Influence

Published in Cell Reports, this study identified significant alterations in liver metabolism among individuals with Down syndrome. These changes include elevated levels of bile acids in the bloodstream and other biomarkers of liver dysfunction.

Key Findings

Elevated Bile Acids: Multiomic analysis of plasma samples from over 400 participants in the Human Trisome Project showed consistently elevated bile acid levels across the lifespan, independent of body mass index or co-occurring conditions.

Cellular Basis: Hepatocytes (liver cells) derived from induced pluripotent stem cells donated by individuals with Down syndrome exhibited intrinsic metabolic dysfunction, including altered bile acid production and abnormally high fat storage.

Mouse Model Validation: The Dp16 mouse model, which shares many genetic features with Down syndrome, displayed liver abnormalities including inflammation, fibrosis, and a ductular reaction. Metabolomic analysis confirmed elevated bile acids, and gene expression profiling indicated disruptions in metabolic and inflammatory signaling pathways.

"Down syndrome impacts hepatic metabolism, and dietary fat intake influenced these effects in mouse models, suggesting nutrition's role in managing liver health." — Kelly Sullivan, senior author

Dietary Influence: In the mouse model, dietary fat intake significantly influenced these outcomes. A high-fat diet exacerbated liver injury and led to steatosis, while a low-fat diet mitigated these effects.

Lauren Dunn, lead author, noted that the findings suggest dietary modification could improve liver and overall health.

The research team plans to explore clinical interventions, including low-fat diets and lifestyle modifications, to determine their impact on liver health in individuals with Down syndrome.